A phase 1b study of trametinib, an oral Mitogen-activated protein kinase kinase (MEK) inhibitor, in combination with gemcitabine in advanced solid tumours
Titel:
A phase 1b study of trametinib, an oral Mitogen-activated protein kinase kinase (MEK) inhibitor, in combination with gemcitabine in advanced solid tumours
Auteur:
Infante, Jeffrey R. Papadopoulos, Kyriakos P. Bendell, Johanna C. Patnaik, Amita Burris III, Howard A. Rasco, Drew Jones, Suzanne F. Smith, Lon Cox, Donna S. Durante, Michael Bellew, Kevin M. Park, Joohyun (Jennifer) Le, Ngocdiep T. Tolcher, Anthony W.